Sponsors (16)
The bill preserves and clarifies funding and statutory authority to support transplants and stem cell research—improving patient access and research prospects—while increasing federal spending and imposing some limits on budget flexibility and administrative burdens.
Patients needing cell transplants will have continued, dedicated program funding ($33,009,000 per year FY2027–FY2031), preserving access to transplants and related services.
Hospitals and transplant centers receive predictable annual funding for program operations and grants, improving planning, staffing, and service continuity at transplant providers.
Researchers and biomedical institutions could gain clearer or expanded statutory authority for stem cell programs, which may accelerate research and development of new stem cell therapies that benefit patients over time.
Taxpayers and the federal budget will face increased mandatory outlays (at least $33,009,000 annually for FY2027–2031) and potential additional costs if program scope is expanded, raising fiscal commitments.
The statutory earmark for this program reduces budget flexibility, potentially crowding out other health priorities in those fiscal years.
Hospitals and research institutions may face new or changed compliance and reporting requirements under the amended statute, creating administrative burdens and potential implementation costs.
Based on analysis of 3 sections of legislative text.
Specifies a $31,009,000 one-time appropriation and $33,009,000 annually for FY2027–FY2031 for the C.W. Bill Young Cell Transplantation Program and replaces a subsection of the stem cell law.
Introduced September 4, 2025 by Christopher Henry Smith · Last progress September 4, 2025
Provides new statutory appropriation language for the federal C.W. Bill Young Cell Transplantation Program by preserving a one-time payment and adding a recurring annual appropriation for fiscal years 2027–2031, and replaces a subsection of the existing Stem Cell Therapeutic and Research Act; also establishes an official short title. The text specifies dollar amounts for program funding but the replacement subsection is not shown in the excerpt, so the scope of programmatic changes there is unclear.